Ron Kooijman Selected Research

Ron Kooijman Research Topics

Disease

8	Infarction (Infarctions) 01/2020 - 04/2009
8	Stroke (Strokes) 01/2020 - 04/2009
6	Ischemic Stroke 01/2020 - 04/2009
6	Brain Ischemia (Cerebral Ischemia) 01/2017 - 04/2009
3	Inflammation (Inflammations) 01/2022 - 04/2002
3	Hypothermia 03/2013 - 05/2011
3	Gliosis 08/2012 - 07/2010
2	Epilepsy (Aura) 12/2021 - 01/2021
2	Seizures (Absence Seizure) 01/2021 - 05/2019
2	Neuroinflammatory Diseases 01/2020 - 11/2010
2	Multiple Sclerosis 01/2019 - 04/2014
2	Prostatic Neoplasms (Prostate Cancer) 10/2011 - 10/2007
2	Neoplasms (Cancer) 01/2009 - 12/2003
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Temporal Lobe Epilepsy 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 01/2019
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017
1	Cicatrix (Scar) 04/2014
1	Major Depressive Disorder (Major Depressive Disorders) 04/2014
1	Encephalitis (Encephalitis, Rasmussen) 04/2014
1	Neuromyelitis Optica (Devic's Disease) 04/2014
1	Ischemia 03/2013
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2010
1	Asthma (Bronchial Asthma) 12/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2009
1	Growth Disorders 01/2009
1	Necrosis 10/2007
1	Infections 06/2007

Drug/Important Bio-Agent (IBA)

9	Endothelin-1 (Endothelin 1)IBA 01/2020 - 05/2011
7	Insulin-Like Growth Factor I (IGF-1)IBA 01/2020 - 10/2007
6	CytokinesIBA 01/2019 - 05/2007
5	Neuroprotective AgentsIBA 01/2019 - 04/2009
2	Ghrelin ReceptorsIBA 12/2021 - 01/2021
2	Anticonvulsants (Antiepileptic Drugs)IBA 12/2021 - 01/2021
2	GhrelinIBA 12/2021 - 01/2021
2	macimorelinIBA 01/2021 - 05/2019
2	Insulin (Novolin)FDA Link 01/2020 - 01/2019
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2016 - 10/2011
2	Caspase 3 (Caspase-3)IBA 03/2013 - 08/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2011 - 10/2007
2	InterleukinsIBA 10/2007 - 12/2003
2	Interleukin-8 (Interleukin 8)IBA 10/2007 - 04/2002
2	Chemotactic FactorsIBA 12/2003 - 04/2002
1	RNA (Ribonucleic Acid)IBA 01/2022
1	LigandsIBA 12/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Minocycline (Cyclops)FDA LinkGeneric 01/2020
1	Vasoconstrictor AgentsIBA 01/2020
1	YIL 781IBA 05/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2017
1	AntibodiesIBA 04/2014
1	Protein Glutamine gamma Glutamyltransferase 2IBA 04/2014
1	Adrenergic Receptors (Adrenergic Receptor)IBA 04/2014
1	Glial Fibrillary Acidic ProteinIBA 08/2012
1	cresyl violetIBA 05/2012
1	LipopolysaccharidesIBA 05/2012
1	DNA (Deoxyribonucleic Acid)IBA 10/2011
1	Phosphodiesterase InhibitorsIBA 12/2010
1	ElementsIBA 11/2010
1	Nerve Growth Factors (Neurotrophins)IBA 07/2010
1	GlycogenIBA 07/2010
1	Insulin-Like Growth Factor Binding ProteinsIBA 04/2009
1	Interleukin-6 (Interleukin 6)IBA 10/2007
1	AndrogensIBA 10/2007
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2007
1	Hormones (Hormone)IBA 05/2007

Therapy/Procedure

4	Therapeutics 03/2013 - 05/2011
1	Resistance Training 01/2022
1	Injections 01/2019
1	Cannula 01/2019
1	Drug Therapy (Chemotherapy) 01/2017
1	Intravenous Injections 01/2016
1	Lasers (Laser) 08/2012